Breathing barriers: bridging lung health, research, and awareness
Hendrik Pott(Philipps University of Marburg), Simon Couillard(Université de Sherbrooke), Jérémy Charriot(Inserm), Lydia Finney(Imperial College London), Mustafa Abdo(German Center for Lung Research), Sanjay Ramakrishnan(Oxford BioMedica (United Kingdom)), Dominic L Sykes(Hull York Medical School), Freda Yang(National Institutes of Health)
Cited by 7
Related Papers
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
|The Lancet Respiratory Medicine|2021|434
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
|The Lancet|2021|310
Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide
|Thorax|2021|169
Survival analysis of patients on maintenance hemodialysis
|Indian Journal of Nephrology|2014|100
Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a double-blind, double-dummy, active placebo-controlled randomised trial
|The Lancet Respiratory Medicine|2024|98